Shahinaz Gadalla
#183,624
Most Influential Person Now
Physician-scientist and cancer epidemiologist
Shahinaz Gadalla's AcademicInfluence.com Rankings
Shahinaz Gadallamedical Degrees
Medical
#3823
World Rank
#4340
Historical Rank
Epidemiology
#840
World Rank
#875
Historical Rank
Shahinaz Gadallaphilosophy Degrees
Philosophy
#12265
World Rank
#17007
Historical Rank
Logic
#9113
World Rank
#11494
Historical Rank
Download Badge
Medical Philosophy
Shahinaz Gadalla's Degrees
- Doctorate Medicine Cairo University
- PhD Epidemiology Johns Hopkins University
Why Is Shahinaz Gadalla Influential?
(Suggest an Edit or Addition)According to Wikipedia, Shahinaz Mohamed Aly Gadalla is a physician-scientist and cancer epidemiologist who researches cancer biomarkers and hematopoietic stem cell transplantation. She is a senior investigator in the clinical genetics branch at the National Cancer Institute.
Shahinaz Gadalla's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research. (2015) (283)
- Population‐based study of autoimmune conditions and the risk of specific lymphoid malignancies (2009) (231)
- Risks of myeloid malignancies in patients with autoimmune conditions (2009) (221)
- Telomere length in blood, buccal cells, and fibroblasts from patients with inherited bone marrow failure syndromes (2010) (123)
- Hematopoietic Malignancies Associated with Viral and Alcoholic Hepatitis (2008) (109)
- Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita. (2013) (106)
- Consensus-based care recommendations for adults with myotonic dystrophy type 1 (2018) (92)
- Cancer risk among patients with myotonic muscular dystrophy. (2011) (86)
- Exploring patient-physician communication in breast cancer care for African American women following primary treatment. (2008) (80)
- Family perspectives on communication with healthcare providers during end-of-life cancer care. (2006) (71)
- Association between donor leukocyte telomere length and survival after unrelated allogeneic hematopoietic cell transplantation for severe aplastic anemia. (2015) (71)
- Telomeres and the natural lifespan limit in humans (2017) (70)
- LINE-1 methylation is inherited in familial testicular cancer kindreds (2010) (62)
- Evaluation of serum biomarkers of fibrosis and injury in Egyptian patients with chronic hepatitis C. (2007) (53)
- Prevalence of smoking among rural secondary school students in Qualyobia governorate. (2003) (53)
- National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Subsequent Neoplasms Working Group Report. (2017) (50)
- A population‐based assessment of mortality and morbidity patterns among patients with thymoma (2011) (50)
- Effect of pre-analytic variables on the reproducibility of qPCR relative telomere length measurement (2017) (49)
- Water pipe (Sisha) smoking in cafes in Egypt. (2003) (45)
- Breast cancer risk in elderly women with systemic autoimmune rheumatic diseases: a population-based case–control study (2009) (45)
- Pesticide Use and Relative Leukocyte Telomere Length in the Agricultural Health Study (2015) (44)
- Hematopoietic Stem Cell Transplantation Activity in Pediatric Cancer between 2008 and 2014 in the United States: A Center for International Blood and Marrow Transplant Research Report. (2017) (41)
- Telomere biology in hematopoiesis and stem cell transplantation. (2011) (40)
- Survival following allogeneic transplant in patients with myelofibrosis. (2020) (39)
- Correlates of tumor development in patients with myotonic dystrophy (2012) (37)
- Patient Understanding of Diabetes Self-Management: Participatory Decision-Making in Diabetes Care (2011) (33)
- Correlation of Leukocyte Telomere Length Measurement Methods in Patients with Dyskeratosis Congenita and in Their Unaffected Relatives (2017) (32)
- HLA Informs Risk Predictions after Haploidentical Stem Cell Transplantation with Post-transplantation Cyclophosphamide. (2021) (31)
- The long and short of telomeres and cancer association studies. (2013) (28)
- Diabetes, Abnormal Glucose, Dyslipidemia, Hypertension, and Risk of Inflammatory and Other Breast Cancer (2017) (26)
- The relationship between DNA methylation and telomere length in dyskeratosis congenita (2012) (26)
- Similar telomere attrition rates in androgen-treated and untreated patients with dyskeratosis congenita. (2018) (25)
- Association Between Aspirin Use and Biliary Tract Cancer Survival (2019) (25)
- Telomere length and risk of glioma. (2013) (24)
- Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia. (2019) (24)
- Effect of Recipient Age and Stem Cell Source on the Association between Donor Telomere Length and Survival after Allogeneic Unrelated Hematopoietic Cell Transplantation for Severe Aplastic Anemia. (2016) (24)
- Increased risk of tumor in DM1 is not related to exposure to common lifestyle risk factors (2016) (24)
- Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide. (2019) (23)
- Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia (2021) (22)
- Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia. (2018) (22)
- Quantifying Cancer Absolute Risk and Cancer Mortality in the Presence of Competing Events after a Myotonic Dystrophy Diagnosis (2013) (21)
- The limitations of qPCR telomere length measurement in diagnosing dyskeratosis congenita (2016) (20)
- Risk of skin cancer among patients with myotonic dystrophy type 1 based on primary care physician data from the U.K. Clinical Practice Research Datalink (2018) (20)
- Prevalence of pathogenic/likely pathogenic variants in the 24 cancer genes of the ACMG Secondary Findings v2.0 list in a large cancer cohort and ethnicity-matched controls (2018) (20)
- Statin use and reduced risk of biliary tract cancers in the UK Clinical Practice Research Datalink (2018) (20)
- Telomeres in molecular epidemiology studies. (2014) (20)
- Method comparison studies of telomere length measurement using qPCR approaches: A critical appraisal of the literature (2020) (20)
- Bile acid synthesis, modulation, and dementia: A metabolomic, transcriptomic, and pharmacoepidemiologic study (2021) (20)
- Cancer phenotype in myotonic dystrophy patients: Results from a meta‐analysis (2018) (18)
- The Effect of Cancer Treatments on Telomere Length: A Systematic Review of the Literature (2018) (18)
- Number of HLA mismatched eplets is not associated with major outcomes in haploidentical transplantation with post-transplantation cyclophosphamide: A Center for International Blood and Marrow Transplant Research Study. (2021) (18)
- Cancer Risk in Myotonic Dystrophy Type I: Evidence of a Role for Disease Severity. (2018) (18)
- Peripheral Blood versus Bone Marrow from Unrelated Donors: Bone Marrow Allografts Have Improved Long-Term Overall and Graft-versus-Host Disease-Free, Relapse-Free Survival. (2019) (18)
- Measurement of Telomere Length for Longitudinal Analysis: Implications of Assay Precision (2021) (17)
- Autoimmune diseases and breast cancer risk by tumor hormone‐receptor status among elderly women (2018) (17)
- Donor telomere length and causes of death after unrelated hematopoietic cell transplantation in patients with marrow failure. (2018) (17)
- Telomere Length Calibration from qPCR Measurement: Limitations of Current Method (2018) (17)
- Correlates of high hepatitis C virus RNA load in a cohort of HIV‐negative and HIV‐positive individuals with haemophilia (2011) (15)
- Evidence-based care for breast cancer survivors: communicating the Institute of Medicine Guidelines in medical practice. (2009) (15)
- Oral cancer exams among cigarette smokers in Maryland. (2006) (14)
- Impact of Previously Unrecognized HLA Mismatches Using Ultrahigh Resolution Typing in Unrelated Donor Hematopoietic Cell Transplantation (2021) (13)
- Genome-wide Association Study Identifies HLA-DPB1 as a Significant Risk Factor for Severe Aplastic Anemia. (2020) (13)
- Bcl‐2 level as a biomarker for 13q14 deletion in CLL (2013) (13)
- Benign and malignant tumors in the UK myotonic dystrophy patient registry (2018) (12)
- Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation. (2019) (12)
- Survival Trends in Infants Undergoing Allogeneic Hematopoietic Cell Transplant (2019) (12)
- Comparison of outcomes of HCT in blast phase of BCR-ABL1- MPN with de novo AML and with AML following MDS. (2020) (11)
- No Association between Donor Telomere Length and Outcomes after Allogeneic Unrelated Hematopoietic Cell Transplant in Patients with Acute Leukemia (2017) (11)
- Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood and Marrow Transplant Research Study (2020) (10)
- A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Myelodysplastic Syndromes Patients. (2020) (10)
- Comparison of total body irradiation versus non-total body irradiation containing regimens for de novo acute myeloid leukemia in children (2020) (10)
- Nicotine dependance among adult male smokers in rural Egypt. (2003) (10)
- Risk factors for Burkitt lymphoma: a nested case‐control study in the UK Clinical Practice Research Datalink (2018) (10)
- Chromosomal Aberrations and Survival after Unrelated Donor Hematopoietic Stem Cell Transplant in Patients with Fanconi Anemia. (2018) (10)
- Pigmentation phenotype, photosensitivity and skin neoplasms in patients with myotonic dystrophy (2017) (10)
- GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia. (2019) (9)
- Clinico-pathologic and mammographic characteristics of inflammatory and non-inflammatory breast cancer at six centers in North Africa (2019) (9)
- Relative Telomere Length before Hematopoietic Cell Transplantation and Outcome after Unrelated Donor Hematopoietic Cell Transplantation for Acute Leukemia. (2017) (8)
- Prognostic significance of pulmonary function tests in dyskeratosis congenita, a telomere biology disorder (2019) (8)
- Impact of Pretransplantation Renal Dysfunction on Outcomes after Allogeneic Hematopoietic Cell Transplantation. (2021) (8)
- Diabetes, metformin and cancer risk in myotonic dystrophy type I (2019) (7)
- NHANES III equations enhance early detection and mortality prediction of bronchiolitis obliterans syndrome after hematopoietic SCT (2014) (7)
- Genetic testing in severe aplastic anemia is required for optimal hematopoietic cell transplant outcomes. (2022) (7)
- Benign tumors in myotonic dystrophy type I target disease‐related cancer sites (2019) (7)
- Benefits of combining prevalent and incident cohorts: An application to myotonic dystrophy (2018) (7)
- Pre‐transplant short telomeres are associated with high mortality risk after unrelated donor haematopoietic cell transplant for severe aplastic anaemia (2019) (7)
- Association of donor IFNL4 genotype and non-relapse mortality after unrelated donor myeloablative haematopoietic stem-cell transplantation for acute leukaemia: a retrospective cohort study. (2020) (6)
- Cancer risk assessment for the primary care physician. (2009) (6)
- Editorial: US Cancer Statistics of Survival: Achievements, Challenges, and Future Directions. (2017) (6)
- Telomere length and epigenetic clocks as markers of cellular aging: a comparative study (2022) (6)
- Effect of Conditioning Regimen Dose Reduction in Obese Patients Undergoing Autologous Hematopoietic Cell Transplantation. (2019) (6)
- Survival patterns and cancer determinants in families with myotonic dystrophy type 1 (2018) (6)
- National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Consensus Recommendations for Subsequent Neoplasms (2017) (5)
- Maintenance tyrosine kinase inhibitors following allo-HCT for chronic myeloid leukemia: A CIBMTR Study. (2019) (5)
- A core group of structurally similar HLA-DPB1 alleles drives permissiveness after hematopoietic cell transplantation. (2022) (5)
- Risk factors for inflammatory and non-inflammatory breast cancer in North Africa (2020) (5)
- DNA-methylation-based telomere length estimator: comparisons with measurements from flow FISH and qPCR (2021) (5)
- Lipid-lowering drugs, dyslipidemia, and breast cancer risk in a Medicare population (2018) (4)
- Pre-HCT mosaicism increases relapse risk and lowers survival in acute lymphoblastic leukemia patients post-unrelated HCT. (2021) (4)
- Menopausal hormone therapy and risk of biliary tract cancers (2021) (4)
- Epigenetic Aging and Hematopoietic Cell Transplantation in Patients With Severe Aplastic Anemia. (2021) (4)
- Specific class I HLA supertypes but not HLA zygosity or expression are associated with outcomes following HLA-matched allogeneic hematopoietic cell transplant: HLA supertypes impact allogeneic HCT outcomes. (2020) (3)
- The role of 5α‐reductase inhibitors in gastro‐oesophageal cancer risk: A nested case‐control study (2019) (3)
- Prognostic impact of pre-transplant chromosomal aberrations in peripheral blood of patients undergoing unrelated donor hematopoietic cell transplant for acute myeloid leukemia (2021) (3)
- Donor Telomere Length and Outcomes after Allogeneic Unrelated Hematopoietic Cell Transplant in Patients with Acute Leukemia (2016) (3)
- Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML (2021) (3)
- Population frequency of Fanconi pathway gene variants and their association with survival after hematopoietic cell transplant for severe aplastic anemia. (2020) (3)
- Non-infectious pulmonary toxicity after allogeneic hematopoietic cell transplantation. (2022) (3)
- Leukocyte telomere length in patients with myotonic dystrophy type I: a pilot study (2019) (3)
- Correlation of Telomere Length in Blood, Buccal Cells, and Fibroblasts From Patients with Inherited Bone Marrow Failure Syndromes. (2009) (3)
- Haploidentical Vs. Matched Unrelated Donor Transplants Using Post-Transplant Cyclophosphamide for Lymphoma: A Joint CIBMTR/EBMT Study (2021) (2)
- Senescence plays a role in myotonic dystrophy type 1 (2022) (2)
- Reproductive Cancer Risk Factors in Women With Myotonic Dystrophy (DM): Survey Data From the US and UK DM Registries (2019) (2)
- Clinical Characteristics and Outcomes of COVID-19 in Pediatric and Early Adolescent and Young Adult Hematopoietic Stem Cell Transplant Recipients: A Cohort Study (2022) (2)
- The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysis (2022) (2)
- Genetics of HLA peptide presentation, and impact on outcomes in HLA-matched allo-HCT. (2021) (2)
- Genetics of HLA Peptide Presentation and Impact on Outcomes in HLA-Matched Allogeneic Hematopoietic Cell Transplantation (2021) (2)
- Germline-somatic JAK2 interactions are associated with clonal expansion in myelofibrosis (2022) (2)
- Molecular landscape of immune pressure and escape in aplastic anemia (2022) (2)
- Erratum to: Increased risk of tumor in DM1 is not related to exposure to common lifestyle risk factors (2016) (2)
- Association of Chronic Graft-versus-Host Disease with Late Effects Following Allogeneic Hematopoietic Cell Transplantation for Children with Hematologic Malignancy. (2022) (1)
- Clonal Alterations and Survival after Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplant in Patients with Fanconi Anemia (2018) (1)
- Evaluating The Utility Of Telomere Length Measurement By Qpcr As a Diagnostic Test For Dyskeratosis Congenita (2013) (1)
- Donor KIR Gene Content and KIR-Ligand Matching and Outcomes of Pediatric Patients with JMML Following Unrelated Donor Transplant. (2021) (1)
- Donor IFNL4 Genotype Is Associated with Transplant-Related Mortality after Unrelated Donor Myeloablative Hematopoietic Cell Transplantation in Patients with Acute Leukemia (2018) (1)
- Aspirin use and survival from biliary tract cancer: Aspirin use and biliary tract cancer survival (2019) (1)
- Decoupling blood telomere length from age in recipients of allogeneic hematopoietic cell transplant in the BMT-CTN 1202 (2022) (1)
- US Cancer Statistics of Survival: Achievements, Challenges, and Future Directions (2017) (1)
- Single HLA Class I Mismatches with High Peptide Divergence in the Graft-Versus-Host Direction Are Associated with Inferior Survival after 9/10 HLA-Matched UD-HCT: A Retrospective Study from the CIBMTR (2021) (1)
- Abstract 2333: Aspirin may extend biliary tract cancer survival: Results from population-based cohort (2019) (1)
- Abstract 1237: Cancer risk in myotonic dystrophy type I: First evidence of a role for disease severity (2018) (1)
- Haploidentical versus matched unrelated donor transplants using post-transplant cyclophosphamide for lymphomas. (2022) (1)
- Telomere length measurement for longitudinal analysis: the role of assay precision (2020) (1)
- Analysis of Mortality Among Transgender and Gender Diverse Adults in England (2023) (1)
- Polychlorinated Biphenyls and Cancer: Are Telomeres to Blame? (2015) (1)
- Pathogenicity and impact of HLA class I alleles in aplastic anemia patients of different ethnicities (2022) (1)
- Readers respond to "balancing evidence-based medicine and cultural competence in the quest to end healthcare disparities". (2006) (1)
- Impact of HLA Molecular Mismatch on Haploidentical Hematopoietic Stem Cell Transplantation: A Center for International Blood and Marrow Transplant Research Study (2021) (0)
- Telomere length in hematopoietic cell transplant. (2020) (0)
- Pre-HCT Telomere Abnormalities and Mortality after Unrelated Donor Hematopoietic Cell Transplant for Severe Aplastic Anemia (2019) (0)
- Running Title : 5 α-reductase inhibitors and gastro-oesophageal cancer risk (2019) (0)
- First Late Effect in Pediatric Survivors with Chronic Graft-Versus-Host Disease Following Hematopoietic Cell Transplantation for Hematologic Malignancy (2021) (0)
- De Novo and Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome: Similarities and Differences in SNP-Array Detected Chromosomal Aberrations in Pre-Transplant Blood Samples (2019) (0)
- Telomere Shortest Length Assay (TeSLA) Defines the Distribution and Accumulation of the Shortest Telomeres in Dyskeratosis Congenita (2022) (0)
- HLA Class I Genotypes with Predicted Strong Binding Affinity to Mutated NPM1 Are Associated with Lower Relapse Risk in Matched Related or Unrelated Transplant for NPM1 Mutated Acute Myeloid Leukemia (2021) (0)
- Abstract 5100: Development of a direct-measurement molecular assay to determine telomere length in human samples (2014) (0)
- JAK2 V617F Mutation and Associated Chromosomal Alterations Involving JAK2 in Pre-HCT Blood Samples and Transplant Outcomes in Myelofibrosis Subtypes (2022) (0)
- Germline Mutations in Patients Receiving Unrelated Donor Hematopoietic Cell Transplant for Severe Aplastic Anemia (2016) (0)
- Whole Exome Sequencing in Severe Aplastic Anemia Identifies Unrecognized Inherited Subset with Inferior Survival after Hematopoietic Cell Transplant (2021) (0)
- Statin Use and Reduced Risk of Biliary Tract Cancers in the United Kingdom Clinical Practice Research Datalink (2018) (0)
- Recipient Pre-HCT Telomere Length and Outcomes after Unrelated Donor HCT for Acute Leukemia (2017) (0)
- HLA Evolutionary Divergence Does Not Predict Relapse and Survival Following Allogeneic Hematopoietic Stem Cell Transplant for Myeloid and Lymphoid Malignancies (2023) (0)
- NHANES III Equations for PFT Interpretation Significantly Alters BOS Diagnoses, Severity, and Prognosis After Hematopoietic Stem Cell Transplantation (HSCT) (2011) (0)
- Single HLA Class I Mismatches with High Peptide Divergence in the Graft-Versus-Host Direction Are Associated with Inferior Survival after 9/10 HLA- Matched UD-HCT: A Retrospective Study from the CIBMTR (2022) (0)
- Buildup from birth onward of short telomeres in human hematopoietic cells. (2023) (0)
- A Refined Model of HLA-DP Permissiveness Improves Stratification of Acute Graft-Versus-Host Disease Risks after Unrelated Hematopoietic Cell Transplantation: A Retrospective Study from the CIBMTR (2021) (0)
- Abstract 2251: Alu retroelement copy number, leukocyte telomere length, and lung cancer risk in the prospective Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial (2022) (0)
- Abstract 4220: Occupational pesticide use and relative leukocyte telomere length in the biomarkers of exposure and effect in agriculture study (2023) (0)
- Donor Telomere Length Predicts Recipient Survival after Allogeneic Hematopoietic Cell Transplantation in Patients with Bone Marrow Failure Syndromes (2014) (0)
- Impact of Donor Age in Haploidentical-PTCy Versus MUD-PTCy HCT in AML patients. (2023) (0)
- Impact of Chronic Graft-Versus-Host Disease on First Late Effect Among Adult Survivors of Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis (2021) (0)
- Improving Donor Selection for Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide through Selective HLA-Mis/Matching (2020) (0)
- Abstract 3009: Measured and genetically-predicted leukocyte telomere length and lung cancer risk in the prospective UK Biobank (2023) (0)
- Pre-Transplant Clonal Mosaicism Is Associated with Increased Relapse and Lower Survival in Acute Lymphoblastic Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplant (2020) (0)
- Prognostic Impact of Pre-Transplant Chromosomal Aberrations Detected By SNP-Array in Patients Undergoing Unrelated Donor Hematopoietic Cell Transplant for Acute Myeloid Leukemia (2020) (0)
- Multimodal Bcl-2 Sub-Populations in CLL. (2009) (0)
- Systemic autoimmune rheumatic diseases and breast cancer risk in elderly women (2008) (0)
- Detection of HLA Loss of Heterozygosity by an MHC Targeted STR Assay (2021) (0)
- Impact of the HLA Immunopeptidome on Survival of Leukemia Patients After Unrelated Donor Transplantation. (2023) (0)
- Germline-Somatic Interactions in Myelofibrosis Susceptibility (2021) (0)
- Effects of DNA extraction, DNA integrity, and laboratory on the precision of qPCR-based telomere length measurement - a multi-lab impartial study (2022) (0)
- Genome-Wide Association Study Identifies an Immune-Related Etiology for Severe Aplastic Anemia (2019) (0)
- Haploidentical Versus Matched Unrelated Donor Transplants for Lymphomas Using Post-Transplant Cyclophosphamide: A Joint CIBMTR/EBMT Study (2022) (0)
- Chromosomal Aberrations in Pre-HCT Blood Samples and Outcomes after Transplantation in Patients with Myelofibrosis (2020) (0)
- Association of Telomere Length with Colorectal Cancer Risk and Prognosis: A Systematic Review and Meta-Analysis (2023) (0)
- Prevalence of pathogenic/likely pathogenic variants in the 24 cancer genes of the ACMG Secondary Findings v2.0 list in a large cancer cohort and ethnicity-matched controls (2018) (0)
- Survival Trends after Allogeneic Hematopoietic Cell Transplant (HCT) in Children Less Than One-Year-Old (Infants) (2018) (0)
- Haploidentical vs matched unrelated donors for patients with ALL: donor age matters more than donor type (2023) (0)
- Prognostic landscape of mitochondrial genome in myelodysplastic syndrome after stem-cell transplantation (2023) (0)
- Drug-Wide Association Study (DWAS): Challenges and Opportunities (2021) (0)
- Donor Lymphocyte Cell-Specific Telomere Length and Causes of Death after Unrelated Hematopoietic Cell Transplant in Patients with Marrow Failure (2017) (0)
- Donor body mass index does not predict graft versus host disease following hematopoietic cell transplantation (2018) (0)
- Alu retroelement copy number and lung cancer risk in the prospective Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial. (2022) (0)
- Telomere length and epigenetic clocks as markers of cellular aging: a comparative study (2022) (0)
- Survival Modelling for Data From Combined Cohorts: Opening the Door to Meta Survival Analyses and Survival Analysis Using Electronic Health Records (2022) (0)
- HLA Class I genotype is associated with relapse risk after allogeneic stem cell transplantation for NPM1-mutated AML. (2023) (0)
- Donor IFNL4 genotype predicts non-relapse mortality after unrelated donor myeloablative hematopoietic cell transplantation for acute leukemia: A retrospective cohort study (2020) (0)
- Whole-genome sequencing identifies novel predictors for hematopoietic cell transplant outcomes for patients with myelodysplastic syndrome: a CIBMTR study (2023) (0)
This paper list is powered by the following services:
Other Resources About Shahinaz Gadalla
What Schools Are Affiliated With Shahinaz Gadalla?
Shahinaz Gadalla is affiliated with the following schools:
